AU2002305290A1 - Dual inhibitors of pde 7 and pde 4 - Google Patents

Dual inhibitors of pde 7 and pde 4

Info

Publication number
AU2002305290A1
AU2002305290A1 AU2002305290A AU2002305290A AU2002305290A1 AU 2002305290 A1 AU2002305290 A1 AU 2002305290A1 AU 2002305290 A AU2002305290 A AU 2002305290A AU 2002305290 A AU2002305290 A AU 2002305290A AU 2002305290 A1 AU2002305290 A1 AU 2002305290A1
Authority
AU
Australia
Prior art keywords
pde
dual inhibitors
inhibitors
dual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002305290A
Inventor
John H. Dodd
William John Pitts
Andrew J. Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2002305290A1 publication Critical patent/AU2002305290A1/en
Withdrawn legal-status Critical Current

Links

AU2002305290A 2001-05-01 2002-04-29 Dual inhibitors of pde 7 and pde 4 Withdrawn AU2002305290A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/287,964 2001-05-01
US60/299,287 2001-06-19
US60/368,752 2002-03-29

Publications (1)

Publication Number Publication Date
AU2002305290A1 true AU2002305290A1 (en) 2002-11-11

Family

ID=

Similar Documents

Publication Publication Date Title
EP1383743A4 (en) Dual inhibitors of pde 7 and pde 4
AU2002363005A1 (en) Derivatives of uk-2a
AU2002213485A1 (en) Inhibitors of protein kinases
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
AU2002338806A1 (en) Pharmaceutical combinations of pde-v inhibitors and other agents
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
PL353535A1 (en) Application of selective pde 10 inhibitor and application of papaverine
AU2002314466A1 (en) Withasol and methods of use
AU2002339348A1 (en) Inhibition of STAT-1
AU2002257587A1 (en) Novel medicament compositions on the basis of anticholinergics and PDE IV inhibitors
AU2002256085A1 (en) Quinoline inhibitors of hyak1 and hyak3 kinases
AU2002306624A1 (en) Heterocyclic analgesic compounds and methods of use thereof
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2002237657A1 (en) Indole-type inhibitors of p38 kinase
AU2002238103A1 (en) Use of beta-lactamase inhibitors as neuroprotectants
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002241211A1 (en) Imidazo-triazine derivatives as pde 5 inhibitors
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2002364911A1 (en) Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use
AU2002305868A1 (en) Inhibitors of reggamma
AU2002306845A1 (en) Telomerase inhibitors and methods of their use
AU2002305290A1 (en) Dual inhibitors of pde 7 and pde 4
AU2002355432A1 (en) Kavalactone compositions and methods of use